Adaptimmune Therapeutics Plc (ADAP) Inventory Turnover Ratio, from second quarter 2025 to second quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Adaptimmune Therapeutics Plc  (NASDAQ: ADAP)
 

Adaptimmune Therapeutics Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Adaptimmune Therapeutics Plc inventory turnover ratio, the Adaptimmune Therapeutics Plc's ability to sell and replace its inventory in the second quarter 2025, sequentially increased to 1.39 in the second quarter 2025, a new company high. Average inventory processing period, for the Adaptimmune Therapeutics Plc in Jun 30 2025 quarter, has decreased to 263 days, compare to 913 days, in the Mar 31 2025 quarter.

Within Healthcare sector 283 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the first quarter 2025, to 1698.

ADAP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Adaptimmune Therapeutics Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADAP Inventory Turnover Ratio (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 1.39 0.4 0.03 - -
ADAP's Total Ranking # 1698 # 0 # 0 # 0 # 0
Average inventory processing period 263 908 11985 - -
Seq. Inventory Growth 100.82 % -96.67 % 290.61 % - -
Seq. Cost of Sales Growth 184.53 % 1155.71 % - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 284
Overall Market # 1698

Inventory Turnover Ratio Statistics
High Average Low
1.39 1.39 1.39
(Jun 30 2025)  



ADAP Company Profile >> Back to ADAP Efficiency Comparisons >> Compare ADAP Inventory Turnover Ratio to its Competitors

Financial Statements
Adaptimmune Therapeutics Plc's Inventories $ 0 Millions Visit ADAP's Balance sheet
Adaptimmune Therapeutics Plc's Cost of Revenues TTM $ 3 Millions Visit ADAP's Income Statement
What are ADAP's Sales? Visit ADAP's Sales by Segment

Other Inventory Turnover Ratios
Adaptimmune Therapeutics Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ADAP's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ADAP's Competitors
Inventory Turnover Ratio for ADAP's Suppliers
Inventory Turnover Ratio for ADAP's Customers

You may also want to know
ADAP's Sales Growth Rates ADAP's Pe Price to earnings ratio ADAP's Receivables Turnover Ratio ADAP's Stock Quote
ADAP's Net Income Growth Rates ADAP's Ps Price to Sales ratio ADAP's Sales per Employee ADAP's Asset Turnover Ratio
ADAP's Net Margin ADAP's Pb Price to Book ratio ADAP's Financial Strength Ratios ADAP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2025 Inventories at quarter ending Jun 30 2025
Aditxt Inc   18.49 $ 0.540  Millions$ 0  Millions
Adapthealth Corp   18.34 $ 2,528.374  Millions$ 138  Millions
Bespoke Extracts Inc  17.28 $ 0.680  Millions$ 0  Millions
Agape Atp Corporation  15.97 $ 0.718  Millions$ 0  Millions
The Oncology Institute Inc   15.68 $ 189.091  Millions$ 12  Millions
Precipio inc   14.70 $ 11.750  Millions$ 1  Millions
Natera Inc   14.69 $ 727.695  Millions$ 50  Millions
Rockwell Medical inc   13.80 $ 72.000  Millions$ 5  Millions
Novavax inc   13.38 $ 126.728  Millions$ 9  Millions
Irhythm Holdings Inc   12.81 $ 198.000  Millions$ 15  Millions
Option Care Health Inc   11.74 $ 4,318.129  Millions$ 368  Millions
Cryo cell International Inc   10.88 $ 7.604  Millions$ 1  Millions
Neuronetics Inc   10.54 $ 48.000  Millions$ 5  Millions
Scorpius Holdings inc   10.29 $ 2.010  Millions$ 0  Millions
Lifemd Inc   10.29 $ 30.000  Millions$ 3  Millions
Genedx Holdings Corp   10.26 $ 118.000  Millions$ 12  Millions
Infusystem Holdings Inc  10.18 $ 63.584  Millions$ 6  Millions
Aspira Women s Health inc   9.49 $ 2.727  Millions$ 0  Millions
Semler Scientific inc   9.44 $ 3.933  Millions$ 0  Millions
Nutriband Inc   9.23 $ 1.692  Millions$ 0  Millions
Puma Biotechnology Inc   9.17 $ 65.875  Millions$ 7  Millions
Invo Fertility Inc   9.04 $ 2.012  Millions$ 0  Millions
Sotera Health Company  8.94 $ 500.000  Millions$ 56  Millions
Myriad Genetics Inc   8.85 $ 245.000  Millions$ 28  Millions
Neuraxis Inc   8.84 $ 0.521  Millions$ 0  Millions
Castle Biosciences Inc   8.80 $ 65.801  Millions$ 7  Millions
National Vision Holdings Inc   8.68 $ 780.491  Millions$ 90  Millions
Harvard Apparatus Regenerative Technology Inc   8.66 $ 0.580  Millions$ 0  Millions
Earth Science Tech Inc   8.27 $ 4.265  Millions$ 1  Millions
Collegium Pharmaceutical Inc   8.18 $ 304.661  Millions$ 37  Millions

Date modified: 2026-06-23T20:00:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.